C-Path and the European Joint Programme on Rare Diseases to Expand Global Impact and Partnership PARIS, France and TUCSON, Ariz., U.S., February 1, 2022 — Critical Path Institute (C-Path), an independent global nonprofit orga
C-Path Appoints Health Outcomes Expert as Executive Director of the Rare Disease COA Consortium Dr. Lindsey Murray will lead C-Path’s New Rare Disease COA Consortium TUCSON, Ariz., January 13, 2022 — Critical Path Institut
C-Path Launches Rare Disease Clinical Outcome Assessment Consortium The Rare Disease COA Consortium aims to advance patient-focused assessment of clinical benefit in treatment trials for rare diseas
C-Path’s ePRO Consortium Announces Rebranding, Changes Name to eCOA Consortium TUCSON, Ariz., January 11, 2022 — Critical Path Institute (C-Path) is pleased to announce the Electronic Patient-Report
C-Path and NICHD to Share Real-world Data to Advance Neonatal Drug Development TUCSON, Ariz., Dec. 1, 2021 — Critical Path Institute’s (C-Path) International Neonatal Consortium (INC) today announced a sem
C-Path Promotes Nick King and Emily Turner to Executive Directors TUCSON, Ariz., November 10, 2021 — Critical Path Institute (C-Path) today announced it has promoted Nicholas King, M.S., as Exec
C-Path and Cure Mito Announce Data Sharing Agreement to Support Treatment Development For Leigh Syndrome and Mitochondrial Disease TUCSON, Ariz., November 9, 2021 — Critical Path Institute (C-Path) and Cure Mito Foundation (Cure Mito) today announced a joint
C-Path Joins New Coalition to Improve Patient Care and Address Unmet Medical Needs through Community-Level Clinical Trials Tools being developed by C-Path’s CURE Drug Repurposing Collaboratory will help incorporate adaptive platform trial protocol
Academic Innovation Leader and Experienced Scientist to Join C-Path’s PKD Consortium Sorin Fedeles, Ph.D., MBA to serve as new Executive Director TUCSON, Ariz., October 14, 2021 – Critical Path Institute (C-Path)
C-Path and Pulse Infoframe Establish Patient-Centered Data Harmonization Partnership to Accelerate Collaborative Research in Rare Disease LONDON, Canada and TUCSON, Ariz., U.S., September 30, 2021, 2021 — Critical Path Institute (C-Path) and Pulse Infoframe announce
